Hasil Pencarian - Jason A. Powell

  • Menampilkan 1 - 8 hasil dari 8
Perbaiki Hasil
  1. 1
    Targeting the integrated stress response in hematologic malignancies

    Targeting the integrated stress response in hematologic malignancies oleh Gus O. Nwosu, Jason A. Powell, Stuart M. Pitson

    Diterbitkan 2022-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Author Correction: Targeting sphingolipid metabolism as an approach for combination therapies in haematological malignancies

    Author Correction: Targeting sphingolipid metabolism as an approach for combination therapies in haematological malignancies oleh Alexander C. Lewis, Craig T. Wallington-Beddoe, Jason A. Powell, Stuart M. Pitson

    Diterbitkan 2021-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Venetoclax therapy and emerging resistance mechanisms in acute myeloid leukaemia

    Venetoclax therapy and emerging resistance mechanisms in acute myeloid leukaemia oleh Gus O. Nwosu, David M. Ross, Jason A. Powell, Stuart M. Pitson

    Diterbitkan 2024-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    The 10th Barossa meeting: Cell Signalling to Cancer Medicine

    The 10th Barossa meeting: Cell Signalling to Cancer Medicine oleh Winnie L. Kan, Barbara J. McClure, Christopher N. Hahn, Jason A. Powell

    Diterbitkan 2024-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    The sphingosine 1-phosphate receptor 2/4 antagonist JTE-013 elicits off-target effects on sphingolipid metabolism

    The sphingosine 1-phosphate receptor 2/4 antagonist JTE-013 elicits off-target effects on sphingolipid metabolism oleh Melissa R. Pitman, Alexander C. Lewis, Lorena T. Davies, Paul A. B. Moretti, Dovile Anderson, Darren J. Creek, Jason A. Powell, Stuart M. Pitson

    Diterbitkan 2022-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Efficacy of an Fc-modified anti-CD123 antibody (CSL362) combined with chemotherapy in xenograft models of acute myelogenous leukemia in immunodeficient mice

    Efficacy of an Fc-modified anti-CD123 antibody (CSL362) combined with chemotherapy in xenograft models of acute myelogenous leukemia in immunodeficient mice oleh Erwin M. Lee, Dean Yee, Samantha J. Busfield, Julie F. McManus, Nik Cummings, Gino Vairo, Andrew Wei, Hayley S. Ramshaw, Jason A. Powell, Angel F. Lopez, Ian D. Lewis, Martin N. McCall, Richard B. Lock

    Diterbitkan 2015-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Resensitising proteasome inhibitor-resistant myeloma with sphingosine kinase 2 inhibition

    Resensitising proteasome inhibitor-resistant myeloma with sphingosine kinase 2 inhibition oleh Melissa K. Bennett, Manjun Li, Melinda N. Tea, Melissa R. Pitman, John Toubia, Paul P.-S. Wang, Dovile Anderson, Darren J. Creek, Robert Z. Orlowski, Briony L. Gliddon, Jason A. Powell, Craig T. Wallington-Beddoe, Stuart M. Pitson

    Diterbitkan 2022-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Protein kinase activity of phosphoinositide 3-kinase regulates cytokine-dependent cell survival.

    Protein kinase activity of phosphoinositide 3-kinase regulates cytokine-dependent cell survival. oleh Daniel Thomas, Jason A Powell, Benjamin D Green, Emma F Barry, Yuefang Ma, Joanna Woodcock, Stephen Fitter, Andrew C W Zannettino, Stuart M Pitson, Timothy P Hughes, Angel F Lopez, Peter R Shepherd, Andrew H Wei, Paul G Ekert, Mark A Guthridge

    Diterbitkan 2013-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: